Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation

Laboratory Investigation

Volumn 74, Issue 6, 1996, Pages 1067-1079

  Kamanna, Vaijinath S ^a   Pai, Rama ^b   Roh, Daeyoung D ^b   Kirschenbaum, Michael A ^b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; LOW DENSITY LIPOPROTEIN; METHYLCELLULOSE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DOSE RESPONSE; GLOMERULOSCLEROSIS; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TRANSFORMED; CELL MOVEMENT; CHEMOKINE CCL2; CYTOKINES; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED BALB C; MONOCYTES; OXIDATION-REDUCTION;

EID: 0029995774     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Avram MM (1989). Similarities between glomerulosclerosis and atherosclerosis in human renal biopsy specimens: A role for lipoprotein glomerulopathy. Am J Med 87:39N-41N.
2. Baccarini M and Stanley ER (1990). Colony stimulating factor-1. In: Habenicht A, editor. Growth factors, differentiation factors and cytokines. Berlin: Springer-Verlag, 188-199.
3. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, and Fogelman AM (1990). Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85:1260-1266.
4. Bloom RD, Florquin S, Singer GG, Brennan DC, and Rubin-Kelley VE (1993). Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int 43:1000-1009.
5. Brady HR, Denton MD, Jimenez W, Takata S, Palliser D, and Brenner BM (1992). Chemoattractant provoke monocyte adhesion to human mesangial cells and mesangial cell injury. Kidney Int 42:480-487.
6. Brown MS and Goldstein JL (1983). Lipoprotein metabolism in the macrophage. Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52:223-261.
7. Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, and Harlan J (1991). Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77:2266-2271.
8. Chomczynski P and Sacchi N (1989). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-160.
9. Cushing SD, Berliner JA, Valente JA, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, and Fogelman AM (1990). Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134-5138.
10. Cushing SD and Fogelman AM (1992). Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler Thromb 12: 78-82.
11. Cybulsky MI and Gimbrone MA Jr (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791.
12. Dasgupta A, Hussain S, and Ahmad S (1992). Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60:56-59.
13. Diamond JR (1991). Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39:S29-S34.
14. Diamond JR, Pesek I, McCarter MD, and Karnvosky MJ (1989). Alterations in rat macrophage function during nephrosis: Synergistic effects of hypercholesterolemia. Am J Pathol 135:711-718.
15. El Nahas AM (1992). Growth factors and glomerular sclerosis. Kidney Int 36:S15-S20.
16. Faggiotto A, Ross R, and Harker L (1984). Sudies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-340.
17. Falk W, Goodwin RHJ, and Leonard EJ (1980). A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239-247.
18. Gerrity RG, Naito HK, Richardson M, and Schwartz CJ (1979). Dietary-induced atherogenesis in swine: Morphology of the intima in prelesion stages. Am J Pathol 95:775-786.
19. Havel RJ, Eder HA, and Bragdon JH (1955). The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353.
20. Henriksen T, Mahoney EM, and Steinberg D (1983). Enhanced macrophage degradation of biologically modified low density lipoprotein. Atherosclerosis 3:149-159.
21. Jadus MR, Pai R, Horansky E, Wepsic HT, Kirschenbaum MA, and Kamanna VS (1994). Hematopoietic colony stimulatory factor formation by murine mesangial cells: Gene expression and biological activity. Biochem Biophysiol Acta 1224:181-188.
22. Kamanna VS and Kirschenbaum MA (1993). Association between very low density lipoprotein and glomerular injury in Zucker obese rats. Am J Nephrol 13:53-58.
23. Kamanna VS and Lee DM (1990). Rat apolipoprotein B differs in solubility properties from human apolipoprotein B. Biochim Biophys Acta 143:119-121.
24. Kamanna VS, Roh DD, and Kirschenbaum MA (1993). Atherogenic lipoproteins: Mediators of glomerular injury. Am J Nephrol 13:1-5.
25. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, and Keane WF (1990). Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37:880-891.
26. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, and O'Donnell MP (1991). Hyperlipdemia and progressive renal disease. Kidney Int 39:S34-S48.
27. Keane WF, O'Donnell MP, Kasiske BL, and Kim Y (1993). Oxidative modification of low density lipoproteins by mesangial cells. J Am Soc Nephrol 4:187-194.
28. Kirschenbaum MA, Jadus MR, Pai R, Wepsic HT, and Kamanna VS (1993). Hematopoietic colony stimulating factor (CSF) production by murine mesangial cells. J Am Soc Nephrol 4:468A.
29. Lee HS, Lee JS, Koh HI, and Ko KW (1991). Intraglomerular lipid deposition in routine biopsies. Clin Nephrol 36:67-75.
30. Lehr H-A, Hubner C, Finckh B, Angermuller S, Nolte D, Beisiegel U, Kohlschutter A, and Messmer K (1991). Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 88:9-14.
31. Lehr H-A, Krober M, Hubner C, Vajkoczy P, Menger MD, Nolte D, Kohlschutter A, and Messmer K (1993). Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice: Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 68:388-395.
32. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P (1993). An atherogenic diet rapidly induces VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion molecule in rabbit aortic endothelium. Arterioscler Thromb 13:197-204.
33. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, and Fogelman AM (1991). Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 87:2253-2257.
34. Libby P and Hansson GK (1991). Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 64:5-15.
35. Lowry OH, Rosebrough MJ, Farr AL, and Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
36. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, and Striker GE (1988). Glomerular epithelial, mesangial and endothelial cell lines from transgenic mice. Kidney Int 33:677-684.
37. Magil AB and Cohen AH (1989). Monocytes and focal glomerulosclerosis. Lab Invest 61:404-409.
38. Magil AB, Frohlich JJ, Innis SM, and Steinbrecher WP (1993). Oxidized low density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243-1250.
39. Mazzone T, Jensen M, and Chait A (1983). Human arterial wall cells secrete factors that are chemotactic for monocytes. Proc Natl Acad Sci USA 80:5094-5097.
40. Moorhead JF (1991). Lipids and progressive kidney disease. Kidney Int 39:S35-S40.
41. Mori T, Bartocci A, Satriano J, Zuckerman A, Stanley R, Santiago A, and Schlondorff D (1990). Mouse mesangial cells produce colony stimulating factor-1 (CSF-1) and express CSF-1 receptor. J Immunol 144:4697-4702.
42. Mufson RA, Aghajanian J, Wong G, Woodhouse D, and Morgan AC (1989). Macrophage colony-stimulating factor enhances monocyte and macrophage antibody dependent cell-mediated cytotoxicity. Cell Immunol 119:182-192.
43. Nolasco FEB, Cameron JS, Hartley B, Coelho A, Hildreth G, and Reuben R (1987). Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31:1160-1166.
44. Pai R, Kirschenbaum MA, and Kamanna VS (1995). Low density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells. Kidney Int 48:1254-1262.
45. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, and Berliner JA (1993). Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92:471-478.
46. Pesek-Diamond I, Ding G, Frye J, and Diamond JR (1992). Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Am J Physiol 263:F776-F783.
47. Pober JS (1988). Cytokine-mediated activation of vascular endothelium: Physiology and pathology. Am J Pathol 133: 426-433.
48. Quinn MT, Parthasarathy S, Fong LG, and Steinberg D (1987). Oxidative modified low density lipoproteins: A potential role in recruitment and retention of monocyte/ macrophages during atherogenesis. Proc Natl Acad Sci USA 84:2995-2998.
49. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, and Lusis AJ (1990). Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature 344:254-257.
50. Rice GE, Munro JM, Corless C, and Bevilacqua MP (1991). Vascular and nonvascular expression of INCAM-110: A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 138:385-393.
51. Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftahi H, Laporte F, Foret M, Favier A, and Cordonnier D (1991). Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57:10-15.
52. Rollins BJ, Stier P, Ernst T, and Wong GG (1989). The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9:4687-4695.
53. Rovin BH and Tan LC (1993). LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225.
54. Rovin BH, Yoshiumura T, and Tan L (1992). Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153.
55. Saito T and Atkins RC (1990). Contribution of mononuclear leukocytes to the progression of experimental focal glomerulosclerosis. Kidney Int 37:1076-1083.
56. Sambrook J, Fritsch EF, and Maniatis T (1989). Extraction, purification and analysis of mRNA. In: Sambrook J, Fritsch EF, Maniatis T, editors. Molecular cloning, vol 1. New York: Cold Spring Harbor Laboratory Press, 7.3-7.84.
57. Sato H, Suzuki S, Kobayashi H, Ogino S, Inomata A, and Arakawa M (1991). Immunohistological localization of apolipoproteins in the glomeruli in renal disease: Specifically apo B and apo E. Clin Nephrol 36:127-133.
58. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, and Schlondorff D (1993a). Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-γ, tumor necrosis factor-α, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971-1978.
59. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, and Schlondorff D (1993b). Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/mcp-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 92:1564-1571.
60. Schlondorff D (1993). Cellular mechanisms of lipid injury in the glomerulus. Am J Kid Dis 22:72-82.
61. Schreiner GF (1991). The role of the macrophage in glomerular injury. Semin Nephrol 11:268-275.
62. Schreiner GF, Cotran RS, Pardo V, and Wnanue ER (1978). A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med 147:369-384.
63. Schreiner GF, Rovin B, and Lefkowith JB (1989). The anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis: The modulation of macrophage migration and eicosanoid metabolism. J Immunol 143:3192-3199.
64. Stanley ER (1985). The macrophage colony-stimulating factor CSF-1. Methods Enzymol 116:564-587.
65. Sterzel RB, Schulze-Lohoff E, and Marx M (1993). Cytokines and mesangial cells. Kidney Int 43(Suppl 39):S26-S31.
66. Strieter RM, Wiggins R, Phan SH, Wharram BL, Showell HJ, Remick DG, Chensue SW, and Kunkel SL (1989). Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem Biophys Res Commun 162:694-700.
67. Wang JM, Griffin JD, Rambaldi A, Chen ZG, and Mantovani A (1988). Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 141:575-579.
68. Yoshimura T and Leonard EJ (1990). Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 145:292-297.
69. Yui MA, Brissette WH, Brennan DC, Wuthrich RP, and Rubin-Kelley VE (1991). Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-Ipr. Am J Pathol 139:255-261.